A detailed history of Simplex Trading, LLC transactions in Caribou Biosciences, Inc. stock. As of the latest transaction made, Simplex Trading, LLC holds 8,613 shares of CRBU stock, worth $17,053. This represents 0.0% of its overall portfolio holdings.

Number of Shares
8,613
Previous 19,212 55.17%
Holding current value
$17,053
Previous $98,000 85.71%
% of portfolio
0.0%
Previous 0.0%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024

SELL
$1.62 - $5.05 $17,170 - $53,524
-10,599 Reduced 55.17%
8,613 $14,000
Q1 2024

Apr 25, 2024

BUY
$4.82 - $8.26 $9,153 - $15,685
1,899 Added 10.97%
19,212 $98,000
Q4 2023

Feb 02, 2024

BUY
$3.58 - $6.25 $45,433 - $79,318
12,691 Added 274.58%
17,313 $99,000
Q3 2023

Nov 01, 2023

SELL
$4.08 - $8.14 $14,031 - $27,993
-3,439 Reduced 42.66%
4,622 $22,000
Q2 2023

Aug 04, 2023

BUY
$4.04 - $5.47 $27,746 - $37,567
6,868 Added 575.69%
8,061 $34,000
Q1 2023

Apr 27, 2023

SELL
$4.3 - $7.78 $15,789 - $28,568
-3,672 Reduced 75.48%
1,193 $6,000
Q4 2022

Feb 02, 2023

SELL
$5.57 - $11.01 $38,967 - $77,025
-6,996 Reduced 58.98%
4,865 $30,000
Q3 2022

Nov 04, 2022

BUY
$5.34 - $12.79 $26,454 - $63,361
4,954 Added 71.72%
11,861 $125,000
Q2 2022

Aug 03, 2022

BUY
$5.1 - $9.74 $21,516 - $41,093
4,219 Added 156.96%
6,907 $37,000
Q1 2022

May 02, 2022

SELL
$8.42 - $15.32 $11,939 - $21,723
-1,418 Reduced 34.53%
2,688 $24,000
Q4 2021

Feb 23, 2022

BUY
$14.59 - $23.26 $59,906 - $95,505
4,106 New
4,106 $61,000

Others Institutions Holding CRBU

About Caribou Biosciences, Inc.


  • Ticker CRBU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 60,840,800
  • Market Cap $120M
  • Description
  • Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1...
More about CRBU
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.